An inside job: Hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii

Infection and Immunity

Volumn 80, Issue 2, 2012, Pages 476-482

  Denkers, Eric Y ^a   Bzik, David J ^b   Fox, Barbara A ^b   Butcher, Barbara A ^a  

^a Department of Obstetrics Gynecology   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; JANUS KINASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; ROP16 SECRETORY PROTEIN; SECRETORY PROTEIN; STAT3 PROTEIN; STAT6 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CHROMATIN; CYTOKINE PRODUCTION; CYTOPLASM; DOWN REGULATION; ENDOPLASMIC RETICULUM; HOST CELL; IMMUNE DEFICIENCY; IN VIVO STUDY; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MACROPHAGE; NEUTROPHIL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PARASITOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TOXOPLASMA GONDII;

ANIMALS; JANUS KINASES; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TOXOPLASMA;

EID: 84857179058     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05974-11     Document Type: Short Survey

References (92)

1. Aliberti J, et al. 2003. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat. Immunol. 4:485-490.
2. Alonzi T, et al. 2001. Essential role of STAT3 in the control of the acutephase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol. Cell. Biol. 21:1621-1632.
3. Behnke MS, et al. 2011. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc. Natl. Acad. Sci. U. S. A. 108:9631-9636.
4. Bierly AL, Shufesky WJ, Sukhumavasi W, Morelli A, Denkers EY. 2008. Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J. Immunol. 181:8445-8491.
5. Bliss SK, Marshall AJ, Zhang Y, Denkers EY. 1999. Human polymorphonuclear leukocytes produce IL-12, TNF-α, and the chemokines macrophage-inflammatory protein-1a and -1b in response to Toxoplasma gondii antigens. J. Immunol. 162:7369 -7375.
6. Boothroyd JC, Dubremetz JF. 2008. Kiss and spit: the dual roles of Toxoplasma rhoptries. Nat. Rev. Microbiol. 6:79-88.
7. Butcher BA, Denkers EY. 2002. Mechanism of entry determines ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production. Infect. Immun. 70:5216 -5224.
8. Butcher BA, et al. 2011. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1- dependent growth control. PLoS Pathog. 7:e1002236.
9. Butcher BA, Kim L, Johnson PF, Denkers EY. 2001. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NFkB. J. Immunol. 167:2193-2201.
10. Butcher BA, et al. 2005. Cutting edge: IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-α in host macrophages. J. Immunol. 174:3148 -3152.
11. Carruthers VB, Sibley LD. 1997. Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. Eur. J. Cell Biol. 73:114 -123.
12. Charron AJ, Sibley LD. 2002. Host cells: mobilizable lipid resources for the intracellular parasite Toxoplasma gondii. J. Cell Sci. 115:3049 -3059.
13. Chen H, et al. 2011. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 147:436-446.
14. Chtanova T, et al. 2008. Dynamics of neutrophil migration in lymph nodes during infection. Immunity 29:487-496.
15. Cook T, et al. 2007. Divergent polyamine metabolism in the Apicomplexa. Microbiology 153:1123-1130.
16. Coppens I, Sinai AP, Joiner KA. 2000. Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. J. Cell Biol. 149:167-180.
17. Courret N, et al. 2006. CD11c and CD11b expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107: 309-316.
18. Croker BA, et al. 2003. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4:540 -545.
19. Debierre-Grockiego F, et al. 2007. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J. Immunol. 179:1129 -1137.
20. Denkers EY, Gazzinelli RT. 1998. Regulation and function of T cellmediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11:569 -588.
21. Denkers EY, Kim L, Butcher BA. 2003. In the belly of the beast: subversion of macrophage proinflammatory signaling cascades during Toxoplasma gondii infection. Cell. Micro. 5:75-83.
22. Dubey JP. 2007. The history and life-cycle of Toxoplasma gondii, p 1-17. In Weiss LM, Kim K (ed), Toxoplasma gondii. The model apicomplexan: perspective and methods. Academic Press, San Diego, CA.
23. Fentress SJ, et al. 2010. Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence. Cell Host Microbe 8:484-495.
24. Fox BA, Chaudhary K, Bzik DJ. 2007. Nucleotides and amino acids, p 265-387. In Ajioka JW, SoldatiD(ed), Toxoplasma: molecular and cellular biology. Horizon Bioscience, Norfolk, VA.
25. Fox BA, Gigley JP, Bzik DJ. 2004. Toxoplasma gondii lacks the enzymes required for de novo arginine biosynthesis and arginine starvation triggers cyst formation. Int. J. Parasitol. 34:323-331.
26. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149:175-180.
27. Gazzinelli RT, Eltoum I, Wynn TA, Sher A. 1993. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151:3672-3681.
28. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated T. gondii vaccine. J. Immunol. 146:286 -292.
29. Gazzinelli RT, Hieny S, Wynn T, Wolf S, Sher A. 1993. IL-12 is required for the T-cell independent induction of IFN-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. U. S. A. 90:6115-6119.
30. + T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α. J. Immunol. 157:798-805.
31. Gilbert LA, Ravindran S, Turetzky JM, Boothroyd JC, Bradley PJ. 2007. Toxoplasma gondii targets a protein phosphatase 2C to the nuclei of infected host cells. Eukaryot. Cell 6:73-83.
32. Hakansson S, Charron AJ, Sibley LD. 2001. Toxoplasma evacuoles: a two-step process of secretion and fusion forms the parasitophorous vacuole. EMBO J. 20:3132-3144.
33. Heimesaat MM, et al. 2006. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J. Immunol. 177:8785-8795.
34. Heimesaat MM, et al. 2007. Exacerbation of murine ileitis by Toll-like receptor 4 meditated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 56:941-948.
35. Huynh M-H, et al. 2003. Rapid invasion of host cells by Toxoplasma requires secretion of the MIC2-M2AP adhesive protein complex.EMBOJ. 22:2082-2090.
36. Jensen KD, et al. 2011. Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. Cell Host Microbe 9:472-483.
37. Kim L, Butcher BA, Denkers EY. 2004. Toxoplasma gondii interferes with lipopolysaccharide-induced mitogen-activated protein kinase activation by mechanisms distinct from endotoxin tolerance. J. Immunol. 172:3003-3010.
38. Kim L, et al. 2006. Toxoplasma gondii genotype determines MyD88- dependent signaling in infected macrophages. J. Immunol. 177:2584-2591.
39. Kim SK, Fouts AE, Boothroyd JC. 2007. Toxoplasma gondii dysregulates IFN-gamma-inducible gene expression in human fibroblasts: insights from a genome-wide transcriptional profiling. J. Immunol. 178:5154-5165.
40. Lang C, Gross U, Luder CG. 2007. Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol. Res. 100:191-203.
41. Lang R, Patel D, Morris JJ, Rutschman RL, Murray PJ. 2002. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169:2253-2263.
42. Lang R, et al. 2003. SOCS regulates the plasticity of gp130 signaling. Nat. Immunol. 4:546 -550.
43. Lee CW, Bennouna S, Denkers EY. 2006. Screening for Toxoplasma gondii regulated transcriptional responses in LPS-activated macrophages. Infect. Immun. 74:1916 -1923.
44. Lee CW, Sukhumavasi W, Denkers EY. 2007. Phosphoinositide-3- kinase-dependent, MyD88-independent induction of CC-type chemokines characterizes the macrophage response to Toxoplasma gondii strains with high virulence. Infect. Immun. 75:5788 -5797.
45. Leng J, Butcher BA, Egan CE, Abdallah DS, Denkers EY. 2009. Toxoplasma gondii prevents chromatin remodeling initiated by TLR-triggered macrophage activation. J. Immunol. 182:489-497.
46. Leng J, Denkers EY. 2009. Toxoplasma gondii inhibits covalent modification of histone H3 at the IL-10 promoter in infected macrophages. PLoS One 4:e7589.
47. Liddiard K, et al. 2006. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter. BMC Mol. Biol. 7:45.
48. Liesenfeld O, et al. 1999. TNF-α, nitric oxide and IFN-γ are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii. Parasite Immunol. 21:365-376.
49. + T cell-dependent, IFN-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184:597-607.
50. Luder CGK, Algner M, Lang C, Bleicher N, Gross U. 2003. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages. Internat. J. Parasitol. 33:833-844.
51. Luder CGK, Lang T, Beurle B, Gross U. 1998. Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin. Exp. Immunol. 112:308 -316.
52. Luder CGK, Walter W, Beuerle B, Maeurer MJ, Gross U. 2001. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1a. Eur. J. Immunol. 31:1475-1484.
53. Manning G, Plowman GD, Hunter T, Sudarsanam S. 2002. Evolution of protein kinase signaling from yeast to man. Trends Biochem. Sci. 27:514-520.
54. Manning G, Young SL, Miller WT, Zhai Y. 2008. The protist, Monosiga brevicollis, has a tyrosine kinase signaling network more elaborate and diverse than found in any known metazoan. Proc. Natl. Acad. Sci. U. S. A. 105:9674 -9679.
55. Mayer BJ. 2008. Clues to the evolution of complex signaling machinery. Proc. Natl. Acad. Sci. U. S. A. 105:9453-9454.
56. McKee AS, Dzierszinski F, Boes M, Roos DS, Pearce EJ. 2004. Functional inactivation of immature dendritic cells by the intracellular parasite Toxoplasma gondii. J. immunol. 173:2632-2640.
57. Mordue DG, Dessai N, Dustin M, Sibley LD. 1999. Invasion by Toxoplasma gondii establishes a moving junction that selectively excludes host cell plasma membrane proteins on the basis of their membrane anchoring. J. Exp. Med. 190:1783-1792.
58. Mordue DG, Hakansson S, Niesman I, Sibley LD. 1999. Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafficking pathways. Exp. Parasitol. 92:87-99.
59. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958 -969.
60. Ness TL, Ewing JL, Hogaboam CM, Kunkel SL. 2006. CCR4 is a key modulator of innate immune responses. J. Immunol. 177:7531-7539.
61. Ong YC, Reese ML, Boothroyd JC. 2010. Toxoplasma rhoptry protein 16 (ROP16) subverts host function by direct tyrosine phosphorylation of STAT6. J. Biol. Chem. 285:28731-28740.
62. Peixoto L, et al. 2010. Integrative genomic approaches highlight a family of parasite-specific kinases that regulate host responses. Cell Host Microbe 8:208 -218.
63. Peterson E, Liesenfeld O. 2007. Clinical disease and diagnostics, p 81-100. In Weiss LM, Kim K (ed), Toxoplasma gondii. The model apicomplexan: perspectives and methods. Academic Press, Amsterdam, Netherlands.
64. Pincus D, Letunic I, Bork P, Lim WA. 2008. Evolution of the phosphotyrosine signaling machinery in premetazoan lineages. Proc. Natl. Acad. Sci. U. S. A. 105:9680 -9684.
65. Reese ML, Zeiner GM, Saeij JP, Boothroyd JC, Boyle JP. 2011. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc. Natl. Acad. Sci. U. S. A. 108:9625-9630.
66. Reich NC, Liu L. 2006. Tracking STAT nuclear traffic. Nat. Rev. Immunol. 6:602-612.
67. Reis e Sousa C, et al. 1997. In vivo microbial stimulation induces rapid CD40L-independent production of IL-12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186:1819 -1829.
68. Robben PM, et al. 2004. Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. J. Immunol. 172:3686 -3694.
69. Rosowski EE, et al. 2011. Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J. Exp. Med. 208:195-212.
70. Saeij JP, et al. 2006. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314:1780 -1783.
71. Saeij JP, et al. 2007. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445:324 -327.
72. Scharton-Kersten T, Yap G, Magram J, Sher A. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1-13.
73. Scharton-Kersten TM, et al. 1996. In the absence of endogenous IFNgamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045-4054.
74. Schwab JC, Beckers CJ, Joiner KA. 1994. The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. Proc. Natl. Acad. Sci. U. S. A. 91:509 -513.
75. Sehgal PB. 2008. Paradigm shifts in the cell biology of STAT signaling. Semin. Cell Dev. Biol. 19:329 -340.
76. Shapira SS, Speirs K, Gerstein A, Caamano J, Hunter CA. 2002. Suppression of NF-kB activation by infection with Toxoplasma gondii. J. Infect. Dis. 185:S66 -S72.
77. Sibley LD. 2003. Toxoplasma gondii: perfecting an intracellular life style. Traffic 4:581-588.
78. Sibley LD, Ajioka JW. 2008. Population structure of Toxoplasma gondii: clonal expansion driven by infrequent recombination and selective sweeps. Annu. Rev. Microbiol. 62:329 -351.
79. Steinfeldt T, et al. 2010. Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol. 8:e1000576.
80. Suss-Toby E, Zimmerberg EJ, Ward GE. 1996. Toxoplasma invasion: the parasitophorous vacuole is formed from host cell plasma membrane and pinches off via a fusion pore. Proc. Natl. Acad. Sci. U. S. A. 93:8413-8418.
81. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. 1988. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240:516-518.
82. + T cells in mice. J. Immunol. 140:3943-3946.
83. Suzuki Y, et al. 2000. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 164:5375-5382.
84. Takeda K, et al. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of stat3 in macrophages and neutrophils. Immunity 10:39-49.
85. Tonkin ML, et al. 2011. Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide. Science 333:463-467.
86. Whitmarsh RJ, et al. 2011. A critical role for SOCS3 in innate resistance to Toxoplasma gondii. Cell Host Microbe 10:224 -236.
87. Wirnsberger G, Hebenstreit D, Posselt G, Horejs-Hoeck J, Duschl A. 2006. IL-4 induces expression of TARC/CCL17 via two STAT6 binding sites. Eur. J. Immunol. 36:1882-1891.
88. Yamamoto M, et al. 2011. ATF6{beta} is a host cellular target of the Toxoplasma gondii virulence factor ROP18. J. Exp. Med. doi:10.1084/ jem.20101660.
89. Yamamoto M, et al. 2009. A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. J. Exp. Med. 206:2747-2760.
90. Yarovinsky F, et al. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308:1626 -1629.
91. Yasukawa H, et al. 2003. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4:551-556.
92. Zimmermann S, Murray PJ, Heeg K, Dalpke AH. 2006. Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-{gamma} signaling. J. Immunol. 176:1840 -1847.